ID Biomedical finalise deal with Tm Technologies:
This article was originally published in Clinica
Executive Summary
ID Biomedical and Tm Technologies have dismissed all litigation claims the Canadian companies had against each other. Under the terms of the agreement, Tm has issued to IDB 1,330,000 common shares of Tm stock (see Clinica No 647, p 16).